Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 5, 1998, Pages 783-793

  Mohammadi, Abbas ^a   Macri, Joseph ^a   Newton, Roger ^b   Romain, Tanya ^a   Dulay, Daisy ^a   Adeli, Khosrow ^a  

^a UNIVERSITY OF WINDSOR   (Canada)

^b PFIZER INC   (United States)

Author keywords

Apolipoprotein B; Atorvastatin; Degradation; HMG CoA reductase inhibitor; Secretion; Translocation

Indexed keywords

APOLIPOPROTEIN B; APROTININ; ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHIONINE;

ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; INHIBITION KINETICS; LIPOGENESIS; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN SECRETION; PROTEIN STABILITY;

EID: 0031832210     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.5.783     Document Type: Article

References (15)

1. Havel R, Hunninghake D, Illingwoflh R, Lees R, Stein E, Tobert J, Lees A, Leon A, Gardner K, Johnson G, Mellies M, Rhymers P, Tun P. Lovastatin (mevinolin) in the treatment of heterozygous familial hyper-cholesterolemia: a multicenter study. Ann Intern Med. 1987;107:609-615.
2. Illingworth D, Sexton G. Hypercholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia. J Clin Invest. 1984;74:1972-1978.
3. Lovastatin Study Group II. Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia: a multicenter study. JAMA. 1986;256:2829-2834.
4. Kohen-Avramoglu RK, Cianflone KM, Sniderman AD. The role of neutral lipid accessible pool in the regulation of secretion of apoB100 lipoprotein particles by HepG2 cells. J Lipid Res. 1995;36:2513-2528.
5. Cianflone K, Yasruel Z, Rodriguez M, Vas D, Sniderman A. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J Lipid Res. 1990;31:2045-2055.
6. Dashti N. The effect of low density lipoproteins, cholesterol and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells. J Biol Chem. 1992;267:7160-7169.
7. Tanaka M, Jingami H, Otani H, Cho M, Ueda Y, Arai H, Nagano Y, Doi T, Yokode M, Kita T. Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesteryl ester contents in rabbit hepatocytes. J Biol Chem. 1993;268:12713-12718.
8. Adeli K. Regulated intracellular degradation of apolipoprotein B in semipermeable HepG2 cells. J Biol Chem. 1994;269:9166-9175.
9. Grundy SM, Vega GL. Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia. J Lipid Res. 1985;26:1464-1475.
10. Arad Y, Ramakrishnan R, Ginsberg H. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production. J Lipid Res. 1990;31:567-582.
11. Lusis A, Taylor B, Quon D, Tollman S, LeBoeuf RC. Genetic factors controlling structure and expression of apolipoproteins B and E in mice. J Biol Chem. 1987;262:7594-7604.
12. Pullinger CR, North JD, Teng BB, Rifici VA, Ronhild de Brito AE, Scott J. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res. 1989;30:1065-1077.
13. Dashti N, Williams D, Alaupovic P. Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. J Lipid Res. 1989;30:1365-1373.
14. Moberly J, Cole T, Alpers D, Moberly JB, Cole TG, Alpers DH, Schonfeld G. Oleic acid stimulation of apolipoprotein B secretion from HepG2 and Caco-2 cells occurs post-transcriptionally. Biochim Biophys Acta. 1990;1042:70-80.
15. Kaptein A, Roodenburg L, Princen H. Butyrate stimulates the secretion of apolipoprotein (apo) A-I and apo B100 by the human hepatoma cell line HepG2. Biochem J. 1991;278:557-564.